NCT04721717 AIM's Writing for Healing: A Workshop for Individuals Living With Paralysis Status RECRUITING Phase N/A
NCT04719403 Determining Feasibility and Acceptability of Sharing Video Recordings With Patients With ALS and Caregivers Status COMPLETED Phase NA
NCT04691011 New Magnetic Resonance Imaging Biomarkers in Amyotrophic Lateral Sclerosis Status COMPLETED Phase NA
NCT04686110 Analysis of Capillary Retinal and Papillary Vascularization in Patients With Amyotrophic Lateral Sclerosis - CAPISLA Status UNKNOWN Phase NA
NCT04681118 Expanded Access Protocol: Repeated Administration of Nurown® (Autologous MSC-NTF Cells) for the Treatment of ALS Status NO_LONGER_AVAILABLE Phase N/A
NCT04654689 Impact of the Combined Treatment of Liposomed Polyphenols With G04CB02 on the ALS Patients Status COMPLETED Phase PHASE2
NCT04651855 The Evaluation of the Effect of Mesenchymal Stem Cells on the Immune System of Patients With ALS Status UNKNOWN Phase PHASE1/PHASE2
NCT04632225 Safety of Engensis in Participants With Amyotrophic Lateral Sclerosis Status COMPLETED Phase PHASE2
NCT04579666 MERIDIAN: A Study to Evaluate the Efficacy and Safety of Pegcetacoplan in Adults With Amyotrophic Lateral Sclerosis (ALS) Status TERMINATED Phase PHASE2
NCT04569435 Study of ANX005 in Adults With Amyotrophic Lateral Sclerosis (ALS) Status COMPLETED Phase PHASE2
NCT04562831 The NO-ALS Study: A Trial of Nicotinamide/Pterostilbene Supplement in ALS. Status ACTIVE_NOT_RECRUITING Phase NA
NCT04518540 Explore Neuroprotective Effect of Lipoic Acid in Amyotrophic Lateral Sclerosis Status UNKNOWN Phase NA
NCT04516096 A Compassionate Use Protocol of AMX0035 for Treatment of Patients With Amyotrophic Lateral Sclerosis (ALS) Status COMPLETED Phase PHASE2/PHASE3
NCT04514952 Individual Patient Expanded Access IND of Autologous HBadMSCs for the Treatment of Amyotrophic Lateral Sclerosis Status NO_LONGER_AVAILABLE Phase N/A
NCT04499963 Trial of Theracurmin for Patients With Amyotrophic Lateral Sclerosis (ALS) Status COMPLETED Phase PHASE2